About Caisson Laboratories
Caisson Laboratories is a company based in United States founded in 2000. Caisson Laboratories has raised $50 thousand across 7 funding rounds from investors including National Science Foundation and National Oceanic and Atmospheric Administration. Caisson Laboratories offers products and services including Cell Culture Media, Antibiotics, Buffers and Supplements, Gelling Agents, and Balanced Salt Solutions. Caisson Laboratories operates in a competitive market with competitors including Abcam, Stem Cell Technologies, Teknova, Meridian Bioscience and BBI Solutions, among others.
- Headquarter United States
- SectorsHealthcare
- Website caissonlabs.com
- Social LinkedIn X
- Legal Name Caisson Laboratories, Inc.
- Total Equity Funding$50K (USD)
in 7 rounds
- Latest Funding Round$50K (USD), Unspecified
Dec 2010
- InvestorsNational Science Foundation
& 1 more
Products & Services of Caisson Laboratories
Caisson Laboratories offers a comprehensive portfolio of products and services, including Cell Culture Media, Antibiotics, Buffers and Supplements, Gelling Agents, and Balanced Salt Solutions.
Media for growing animal and plant cells in research labs
Antibiotics to prevent contamination in cell culture processes
Solutions for maintaining cell culture environments effectively
Agents used for solidifying media in plant tissue culture
Salts for maintaining osmotic balance in cell cultures
Funding Insights of Caisson Laboratories
Caisson Laboratories has successfully raised a total of $50K across 7 strategic funding rounds. The most recent funding activity was a Unspecified round of $50 thousand completed in December 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $50,000
- Total Rounds 7
- Last Round Unspecified — $50,000
- First Round $1.35M
(Sep 2007)
- Investors Count 2
All 7 funding rounds of Caisson Laboratories with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2010 | $50,000 | Unspecified | – | – | – |
| Jan 2010 | $149,997 | Grant | – | – | |
| Nov 2009 | $149,997 | Grant | – | – | |
| May 2009 | $1.35M | Grant | – | – | |
| Jun 2008 | $119,989 | Grant | – | – | |
| Jan 2008 | $119,989 | Grant | – | – | |
| Sep 2007 | $1.35M | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Caisson Laboratories
Caisson Laboratories has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include National Science Foundation and National Oceanic and Atmospheric Administration.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States | |
- | – | noaa.gov | - |
Investor details for Caisson Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Caisson Laboratories
1 people are tracked at Caisson Laboratories (1 in leadership).
| Name | Role | Group |
|---|---|---|
Ross Farmer | Pres. & CEO | Leadership |
Complete people profiles for Caisson Laboratories
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Caisson Laboratories
3 dated milestones of Caisson Laboratories across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Caisson Laboratories is founded.
- Funding First funding round of $1.3M.
- Funding Latest funding round, Unspecified, of $50K.
Competitors of Caisson Laboratories
Caisson Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, Teknova, Meridian Bioscience and BBI Solutions, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| teknova.com | 1996 | Hollister, United States | – | 290 | Molecular biology reagents and kits are supplied for research applications. | |
| meridianbioscience.com | 1976 | Ohio, United States | – | – | Molecular diagnostic device and kits | |
| bbisolutions.com | 1986 | Crumlin, United Kingdom | – | 301 | Kits and reagents are developed for life science research applications. | |
| sangon.com | 2003 | Shanghai, China | $300M | – | Research services, reagents, and kits for biotech applications are provided. | |
| biochain.com | 1994 | Hayward, United States | $7.34M | 24 | Provider of products and services for clinical diagnosis, genomics, and proteomics | |
| caymanchem.com | 1980 | Ann Arbor, United States | – | 309 | Bioreagents and assay kits are developed, with preclinical services provided. | |
| biolamina.com | 2008 | Sundbyberg, Sweden | $18.25M | – | Recombinant laminins are produced for stem cell culture matrices. |
Detailed competitors of Caisson Laboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Caisson Laboratories
The website of Caisson Laboratories (caissonlabs.com) receives about 5.2K visits a month.
- Monthly visits5.2K
▼ 12.6% vs previous month
Websites whose visitors overlap most with Caisson Laboratories. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| phytotechlab.com | 100% | – | #1,000,042 | View details | |
| zen-bio.com | 70% | 10.8K | #2,170,365 | View details | |
| appliedgenetics.com | 70% | 1.2K | #13,396,451 | View details | |
axday.fr | axday.fr | 70% | – | – | – |
ukncc.co.uk | ukncc.co.uk | 70% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 17 similar websites and full traffic analytics for Caisson Laboratories
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 17 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Caisson Laboratories
10 companies that operate in the same segment as Caisson Laboratories (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Caisson Laboratories
Caisson Laboratories was founded in 2000 and raised its 1st funding round 7 years after it was founded.
Caisson Laboratories is headquartered in United States.
Caisson Laboratories is a funded company, having raised a total of $50K across 7 funding rounds to date. The company's 1st funding round was a Grant of $1.35M, raised on Sep 2007.
Caisson Laboratories was founded in 2000 in the United States, focusing on biotechnology for cell culture applications. Products such as animal cell culture media, fetal bovine serum, buffer solutions, antimicrobials, and reagents are produced and distributed. For plant research and micropropagation, tissue culture media, plant growth regulators, agars, and biochemicals are supplied. A merger with Apomyx occurred in 2003, incorporating development of plant-based technologies for food, energy, and pharmaceutical uses.
Caisson Laboratories's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.
Caisson Laboratories offers Cell Culture Media, Antibiotics, Buffers and Supplements, Gelling Agents, and Balanced Salt Solutions.
Caisson Laboratories has 2 investors. Key investors include National Science Foundation, and National Oceanic and Atmospheric Administration.
Caisson Laboratories operates through Caisson Laboratories, Inc..